Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nils Edvardsson

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Nature Medicine|December 13, 2023
Inhibition of the K<sub>Ca</sub>2 potassium channel in atrial fibrillation: a randomized phase 2 trialAnders G Holst, János Tomcsányi, Birgitte Vestbjerg, et al.
Frontiers in Pharmacology|June 2, 2020
Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in ManBo Hjorth Bentzen, Sofia Hammami Bomholtz, Rafel Simó-Vicens, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 25, 2010
Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registryNils Edvardsson, Viveka Frykman, Rob van Mechelen, et al.
Clinical and Translational Science|July 30, 2020
First Clinical Study with AP30663 - a K<sub>Ca</sub> 2 Channel Inhibitor in Development for Conversion of Atrial FibrillationPim Gal, Erica S Klaassen, Kirsten R Bergmann, et al.
British Journal of Clinical Pharmacology|November 22, 2023
A phase 1 trial of AP30663, a K<sub>Ca</sub>2 channel inhibitor in development for conversion of atrial fibrillationChristina Yfanti, Birgitte Vestbjerg, Juliette Van't Westende, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Nature Medicine|December 13, 2023
Inhibition of the K<sub>Ca</sub>2 potassium channel in atrial fibrillation: a randomized phase 2 trialAnders G Holst, János Tomcsányi, Birgitte Vestbjerg, et al.
Frontiers in Pharmacology|June 2, 2020
Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in ManBo Hjorth Bentzen, Sofia Hammami Bomholtz, Rafel Simó-Vicens, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 25, 2010
Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registryNils Edvardsson, Viveka Frykman, Rob van Mechelen, et al.
Clinical and Translational Science|July 30, 2020
First Clinical Study with AP30663 - a K<sub>Ca</sub> 2 Channel Inhibitor in Development for Conversion of Atrial FibrillationPim Gal, Erica S Klaassen, Kirsten R Bergmann, et al.
British Journal of Clinical Pharmacology|November 22, 2023
A phase 1 trial of AP30663, a K<sub>Ca</sub>2 channel inhibitor in development for conversion of atrial fibrillationChristina Yfanti, Birgitte Vestbjerg, Juliette Van't Westende, et al.
Pageof 9